Biblio

Export 3288 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
E. Zupanic, Kåreholt, I., Norrving, B., Secnik, J., von Euler, M., Winblad, B., Religa, D., Kramberger, M. Gregoric, Johnell, K., Eriksdotter, M., and Garcia-Ptacek, S., “Acute Stroke Care in Dementia: A Cohort Study from the Swedish Dementia and Stroke Registries.”, J Alzheimers Dis, vol. 66, no. 1, pp. 185-194, 2018.
E. Niemantsverdriet, Feyen, B. F. E., Le Bastard, N., Martin, J. - J., Goeman, J., De Deyn, P. Paul, Bjerke, M., and Engelborghs, S., “Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort.”, J Alzheimers Dis, vol. 63, no. 1, pp. 373-381, 2018.
R. L. H. Handels, Joore, M. A., Vos, S. J. B., Aalten, P., Ramakers, I. H. G. B., Rikkert, M. Olde, Scheltens, P., Jansen, W. J., Visser, P. - J., van Berckel, B. M. N., van Domburg, P., Smid, M., Hoff, E., Hoogmoed, J., Bouwman, F., Claassen, J., Leentjens, A. F. G., Wolfs, C. A. G., Severens, J. L., and Verhey, F. R. J., “Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective Cohort.”, J Alzheimers Dis, vol. 52, no. 3, pp. 875-85, 2016.
Q. Wang, Guo, L., Thompson, P. M., Jack, C. R., Dodge, H., Zhan, L., and Zhou, J., “The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1.”, J Alzheimers Dis, vol. 64, no. 1, pp. 149-169, 2018.
B. Polis and Samson, A. O., “Addressing the Discrepancies Between Animal Models and Human Alzheimer's Disease Pathology: Implications for Translational Research.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1199-1218, 2024.
B. Arosio, Casati, M., Gussago, C., Ferri, E., Abbate, C., Scortichini, V., Colombo, E., Rossi, P. Dionigi, and Mari, D., “Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer's Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A New/Old Potential Target.”, J Alzheimers Dis, vol. 54, no. 2, pp. 417-25, 2016.
O. Turró-Garriga, Calvó-Perxas, L., Vilalta-Franch, J., Hernández-Ferrándiz, M., Flaqué, M., Linares, M., Cullell, M., Gich, J., Casas, I., Perkal, H., and Garre-Olmo, J., “Adherence to Clinical Practice Guidelines during Dementia Work-Up in a Real-World Setting: A Study from the Registry of Dementias of Girona.”, J Alzheimers Dis, vol. 59, no. 3, pp. 997-1007, 2017.
M. Waragai, Ho, G., Takamatsu, Y., Wada, R., Sugama, S., Takenouchi, T., Masliah, E., and Hashimoto, M., “Adiponectin Paradox as a Therapeutic Target in Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1249-1253, 2020.
E. Diehl-Wiesenecker, von Armin, C. A. F., Dupuis, L., Müller, H. - P., Ludolph, A. C., and Kassubek, J., “Adipose Tissue Distribution in Patients with Alzheimer's Disease: A Whole Body MRI Case-Control Study.”, J Alzheimers Dis, 2015.
A. Jenkins, Lindsay, S., Eslambolchilar, P., Thornton, I. M., and Tales, A., “Administering Cognitive Tests Through Touch Screen Tablet Devices: Potential Issues.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1169-1182, 2016.
J. C. DiFrancesco, Tremolizzo, L., Polonia, V., Giussani, G., Bianchi, E., Franchi, C., Nobili, A., Appollonio, I., Beghi, E., and Ferrarese, C., “Adult-Onset Epilepsy in Presymptomatic Alzheimer's Disease: A Retrospective Study.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1267-1274, 2017.
K. M. Hawkins and Sergio, L. E., “Adults at Increased Alzheimer's Disease Risk Display Cognitive-Motor Integration Impairment Associated with Changes in Resting-State Functional Connectivity: A Preliminary Study.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1161-72, 2016.
D. L. Alkon, Sun, M. - K., Tuchman, A. J., and Thompson, R. E., “Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial.”, J Alzheimers Dis, vol. 96, no. 2, pp. 759-766, 2023.
J. E. Manousakis, Scovelle, A. J., Rajaratnam, S. M. W., Naismith, S. L., and Anderson, C., “Advanced Circadian Timing and Sleep Fragmentation Differentially Impact on Memory Complaint Subtype in Subjective Cognitive Decline.”, J Alzheimers Dis, vol. 66, no. 2, pp. 565-577, 2018.
B. Dubois, Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. Luis, Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., Cappa, S., Crutch, S., Engelborghs, S., Frisoni, G. B., Fox, N. C., Galasko, D., Habert, M. - O., Jicha, G. A., Nordberg, A., Pasquier, F., Rabinovici, G., Robert, P., Rowe, C., Salloway, S., Sarazin, M., Epelbaum, S., de Souza, L. C., Vellas, B., Visser, P. J., Schneider, L., Stern, Y., Scheltens, P., and Cummings, J. L., “Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.”, Lancet Neurol, vol. 13, no. 6, pp. 614-29, 2014.
K. E. Osborn, Alverio, J. M., Dumitrescu, L., Pechman, K. R., Gifford, K. A., Hohman, T. J., Blennow, K., Zetterberg, H., and Jefferson, A. L., “Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 71, no. 1, pp. 281-290, 2019.
R. McClure, Ong, H., Janve, V., Barton, S., Zhu, M., Li, B., Dawes, M., W Jerome, G., Anderson, A., Massion, P., Gore, J. C., and Pham, W., “Aerosol Delivery of Curcumin Reduced Amyloid-β Deposition and Improved Cognitive Performance in a Transgenic Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 797-811, 2017.
F. Rajabli, Seixas, A. A., Akgun, B., Adams, L. D., Inciute, J., Hamilton, K. L., Whithead, P. G., Konidari, I., Gu, T., Arvizu, J., Golightly, C. G., Starks, T. D., Laux, R., Byrd, G. S., Haines, J. L., Beecham, G. W., Griswold, A. J., Vance, J. M., Cuccaro, M. L., and Pericak-Vance, M. A., “African Ancestry Individuals with Higher Educational Attainment Are Resilient to Alzheimer's Disease Measured by pTau181.”, J Alzheimers Dis, vol. 98, no. 1, pp. 221-229, 2024.
R. J. Piers, Devlin, K. N., Ning, B., Liu, Y., Wasserman, B., Massaro, J. M., Lamar, M., Price, C. C., Swenson, R., Davis, R., Penney, D. L., Au, R., and Libon, D. J., “Age and Graphomotor Decision Making Assessed with the Digital Clock Drawing Test: The Framingham Heart Study.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1611-1620, 2017.
H. Li, Zhu, H., Wallack, M., Mwamburi, M., Abdul-Hay, S. O., Leissring, M. A., and Qiu, W. Qiao, “Age and its association with low insulin and high amyloid-β peptides in blood.”, J Alzheimers Dis, vol. 49, no. 1, pp. 129-37, 2016.
M. A. Garcia, Ortiz, K., Arévalo, S. P., Diminich, E. D., Briceño, E., Vega, I. E., and Tarraf, W., “Age of Migration and Cognitive Function Among Older Latinos in the United States.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1493-1511, 2020.
C. Thygesen, Metaxas, A., Larsen, M. R., and Finsen, B., “Age-Dependent Changes in the Sarkosyl-Insoluble Proteome of APPSWE/PS1ΔE9 Transgenic Mice Implicate Dysfunctional Mitochondria in the Pathogenesis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1247-1259, 2018.
T. A. Couttas, Kain, N., Tran, C., Chatterton, Z., Kwok, J. B., and Don, A. S., “Age-Dependent Changes to Sphingolipid Balance in the Human Hippocampus are Gender-Specific and May Sensitize to Neurodegeneration.”, J Alzheimers Dis, 2018.
T. L. Emmerzaal, Rodenburg, R. J., Tanila, H., Verweij, V., Kiliaan, A. J., and Kozicz, T., “Age-Dependent Decrease of Mitochondrial Complex II Activity in a Familial Mouse Model for Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 1, pp. 75-82, 2018.
T. Minh Do, Dodacki, A., Alata, W., Calon, F., Nicolic, S., Scherrmann, J. - M., Farinotti, R., and Bourasset, F., “Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).”, J Alzheimers Dis, vol. 49, no. 2, pp. 287-300, 2016.

Pages